Cargando…
The neuroleptic drug pimozide inhibits stem-like cell maintenance and tumorigenicity in hepatocellular carcinoma
Drug repurposing is currently an important approach for accelerating drug discovery and development for clinical use. Hepatocellular carcinoma (HCC) presents drug resistance to chemotherapy, and the prognosis is poor due to the existence of liver cancer stem-like cells. In this study, we investigate...
Autores principales: | Chen, Jia-Jie, Cai, Nan, Chen, Guan-Zhong, Jia, Chang-Chang, Qiu, Dong-Bo, Du, Cong, Liu, Wei, Yang, Yang, Long, Zi-Jie, Zhang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392272/ https://www.ncbi.nlm.nih.gov/pubmed/26061710 http://dx.doi.org/10.18632/oncotarget.4307 |
Ejemplares similares
-
Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer
por: Chen, Jia-Jie, et al.
Publicado: (2019) -
Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide
por: Fako, Valerie, et al.
Publicado: (2016) -
Pimozide: An Old Wine in a New Bottle!
por: Naguy, Ahmed
Publicado: (2017) -
PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide
por: Zhao, Tiesuo, et al.
Publicado: (2019) -
Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein
por: Morishita, Hiroki, et al.
Publicado: (2020)